Pharmacokinetics and hemodynamic and diuretic/natriuretic effects of felodipine administered as an extended-release tablet
- PMID: 2081141
- DOI: 10.1007/BF02026497
Pharmacokinetics and hemodynamic and diuretic/natriuretic effects of felodipine administered as an extended-release tablet
Abstract
In this study the pharmacokinetics, and the hemodynamic and diuretic/natriuretic effects of three different doses of felodipine ER-10, 20, and 40 mg--were evaluated in healthy subjects. There was a linear correlation between the dose of felodipine, Cmax, and AUC24, showing that the absorption was linearly related to the dose. The diastolic blood pressure was reduced by 15-20% after the two highest doses. The maximal blood-pressure lowering effect was seen 4 hours after drug intake, and a small reduction in diastolic blood pressure was still present after 24 hours. This was, however, not statistically significant but was related to a sustained effective plasma concentration of the drug (6 nmol/l). Systolic blood pressure was not affected. The two highest doses of felodipine ER produced a significant increase in heart rate 2 and 6 hours after the dose, compared with placebo. There was also a significant decrease in forearm vascular resistance after the 20- and 40-mg doses. Both diuresis and natriuresis were significantly increased by about 100% each during the first 4 hours after the 20-mg dose. Following the 40-mg dose, diuresis and natriuresis were lower than after 20 mg and were not significantly different from placebo.
Similar articles
-
Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.Drugs. 1992 Aug;44(2):251-77. doi: 10.2165/00003495-199244020-00008. Drugs. 1992. PMID: 1382018 Review.
-
The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects.Eur J Clin Pharmacol. 1993;45(4):327-32. doi: 10.1007/BF00265949. Eur J Clin Pharmacol. 1993. PMID: 8299664 Clinical Trial.
-
Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses.Eur J Clin Pharmacol. 1995;47(5):395-400. doi: 10.1007/BF00196851. Eur J Clin Pharmacol. 1995. PMID: 7720759 Clinical Trial.
-
Dose-dependent effects of felodipine on diuresis and natriuresis in healthy subjects.J Cardiovasc Pharmacol. 1988 Aug;12(2):134-9. doi: 10.1097/00005344-198808000-00002. J Cardiovasc Pharmacol. 1988. PMID: 2459543 Clinical Trial.
-
Comparison of felodipine extended release and conventional tablets in essential hypertension using ambulatory blood pressure monitoring.J Hypertens. 1989 Aug;7(8):645-51. doi: 10.1097/00004872-198908000-00008. J Hypertens. 1989. PMID: 2681410 Review.
Cited by
-
Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.Drugs. 1992 Aug;44(2):251-77. doi: 10.2165/00003495-199244020-00008. Drugs. 1992. PMID: 1382018 Review.
-
A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction Modeling.Pharmaceutics. 2022 Jul 15;14(7):1474. doi: 10.3390/pharmaceutics14071474. Pharmaceutics. 2022. PMID: 35890369 Free PMC article.
-
The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects.Eur J Clin Pharmacol. 1993;45(4):327-32. doi: 10.1007/BF00265949. Eur J Clin Pharmacol. 1993. PMID: 8299664 Clinical Trial.
-
Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses.Eur J Clin Pharmacol. 1995;47(5):395-400. doi: 10.1007/BF00196851. Eur J Clin Pharmacol. 1995. PMID: 7720759 Clinical Trial.
-
Development of a reservoir type prolonged release system with felodipine via simplex methodology.Clujul Med. 2016;89(1):128-36. doi: 10.15386/cjmed-526. Epub 2016 Jan 15. Clujul Med. 2016. PMID: 27004036 Free PMC article.